ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.
äŒæ¥ã³ãŒãZIMV
äŒç€ŸåZimVie Inc
äžå Žæ¥Feb 14, 2022
æé«çµå¶è²¬ä»»è
ãCEOãMr. Vafa Jamali
åŸæ¥å¡æ°1770
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Feb 14
æ¬ç€Ÿæåšå°4555 Riverside Drive
éœåžPALM BEACH GARDENS
蚌åžååŒæNASDAQ Global Select Consolidated
åœUnited States of America
éµäŸ¿çªå·33410
é»è©±çªå·18003425454
ãŠã§ããµã€ãhttps://www.zimvie.com/en
äŒæ¥ã³ãŒãZIMV
äžå Žæ¥Feb 14, 2022
æé«çµå¶è²¬ä»»è
ãCEOãMr. Vafa Jamali
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã